Developer docs
API playgroundTry for free, no card

Search company profiles

BBD BioPhenix

Full company profile

uuid002bs6m

Namestring
BBD BioPhenix
Legal namestring
BBD BIOPHENIX S.L
Websiteurl
biobide.es
Company typeenum
Private
Founded yearint
2005
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDonostia-san Sebastián, Spain
HQ citystring
Donostia-san Sebastián
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical drug discovery, zebrafish toxicity assays, contract research services, ecotoxicology testing, GLP-compliant screening
Industry3 codes
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical CRO Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

CRO services for pharma, biotech, chemical, cosmetic and nutraceutical companies providing preclinical zebrafish-based toxicity and efficacy testing under GLP conditions.

biobide.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BBD BioPhenix (Biobide) is a Contract Research Organization (CRO) providing specialized zebrafish-based preclinical testing services for drug discovery and safety assessment. The company delivers Good Laboratory Practice (GLP)-compliant toxicity and efficacy assays organized into general toxicity, specific-organ toxicity, ecotoxicology, and disease model categories. Services are conducted at its Miramon Technology Park facility in San Sebastian, which houses up to 80,000 adult zebrafish.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Reduced drug development failure rate through early toxicity screening
Product overview1 text field

Biobide (BBD BioPhenix) operates as a Contract Research Organization (CRO) providing specialized zebrafish-based testing services for preclinical drug discovery and safety assessment. The company's service portfolio includes Good Laboratory Practice (GLP)-compliant toxicity and efficacy assays organized into four main categories: General Toxicity Assays (Acutetox, Teratotox), Specific-Organ Toxicity Assays (Hepatotox, Cardiotox, Neurotox, Ototox, Immunotox, Muscle Toxicity, Kidney Toxicity, Multitox), Ecotoxicology Assays (EASZY Assay for estrogen pathway, Daphnia Immobilization, Algae Growth Inhibition, Thyroid Disruption), and Efficacy/Disease Models (Antioxidation, Regeneration, Melanin Quantification, Cancer Angiogenesis, Neurodegenerative/Rare Diseases, ALS Models, Sperm Quality, Disease Model Generation, Target Validation). The company also offers specialized reproductive services including zebrafish sperm cryopreservation and in vitro fertilization. All services are conducted at the company's Miramon Technology Park facility in San Sebastian, which houses up to 80,000 adult zebrafish.

Product and service24 records
1Acutetox Assay
CategoryGeneral Toxicity Assays
Description

General toxicity screening assay using zebrafish embryos to assess acute toxic effects of compounds, available in general and ecotoxicology variants.

2Teratotox Assay
CategoryGeneral Toxicity Assays
Description

General toxicity assay evaluating teratogenic effects (developmental malformations) in zebrafish embryos.

3Cardiotox Assay
CategorySpecific-Organ Toxicity Assays
Description

Specific toxicity assay evaluating cardiovascular toxicity effects in zebrafish models.

4Neurotox Assay
CategorySpecific-Organ Toxicity Assays
Description

Specific toxicity assay assessing neurotoxic effects using zebrafish models.

5Hepatotox Assay
CategorySpecific-Organ Toxicity Assays
Description

Specific toxicity assay evaluating hepatotoxicity (liver toxicity) in zebrafish models.

6Nephrotox/Kidney Toxicity Assay
CategorySpecific-Organ Toxicity Assays
Description

Specific toxicity assay assessing kidney toxicity effects in zebrafish models.

7Ototox Assay
CategorySpecific-Organ Toxicity Assays
Description

Specific toxicity assay assessing ototoxicity (hearing/ear toxicity) in zebrafish models.

8Immunotox Assay
CategorySpecific-Organ Toxicity Assays
Description

Specific toxicity assay evaluating immunotoxicity effects in zebrafish models.

9Muscle Toxicity Assay
CategorySpecific-Organ Toxicity Assays
Description

Specific toxicity assay assessing muscle toxicity effects in zebrafish models.

10Multitox Assay
CategorySpecific-Organ Toxicity Assays
Description

Comprehensive multi-parameter toxicity assessment screening multiple toxicity endpoints simultaneously in zebrafish.

11EASZY Assay (Estrogen Pathway)
CategoryEcotoxicology Assays
Description

Ecotoxicology assay evaluating estrogen pathway disruption using zebrafish, specifically designed for endocrine disruptor screening.

12Daphnia Immobilization Test
CategoryEcotoxicology Assays
Description

Ecotoxicology assay assessing acute toxicity to Daphnia (water fleas) for environmental hazard characterization.

13Microplate Alga Growth Inhibition Test
CategoryEcotoxicology Assays
Description

Ecotoxicology assay evaluating effects on algal growth for environmental toxicity assessment.

14Thyroid Disruption Assay
CategoryEcotoxicology Assays
Description

Ecotoxicology assay assessing thyroid endocrine disruption effects in zebrafish models.

15Zebrafish Sperm Cryopreservation and In Vitro Fertilization
CategoryReproductive Biology Services
Description

Specialized reproductive biology service for zebrafish strain preservation and controlled breeding experiments.

16Antioxidation Assay
CategoryEfficacy Assays
Description

Efficacy assay evaluating antioxidant properties and effects of test compounds.

17Regeneration Assay
CategoryEfficacy Assays
Description

Efficacy assay assessing tissue regeneration capacity in zebrafish models.

18Melanin Quantification Assay
CategoryEfficacy Assays
Description

Efficacy assay for measuring melanin content and pigmentation effects in zebrafish.

19Cancer Angiogenesis Inhibition Assay
CategoryEfficacy Assays
Description

Efficacy assay evaluating anti-angiogenic properties of compounds for cancer therapeutic development.

20Neurodegenerative and Rare Diseases Models
CategoryDisease Model Generation
Description

Efficacy and disease model services for studying neurodegenerative disorders and rare diseases using zebrafish models.

21Zebrafish Models for Amyotrophic Lateral Sclerosis (ALS)
CategoryDisease Model Generation
Description

Specific disease model service using zebrafish to study ALS pathophysiology and test therapeutic candidates.

22Sperm Quality Assessment
CategoryReproductive Biology Services
Description

Reproductive toxicology service evaluating zebrafish sperm quality parameters.

23Disease Model Generation
CategoryDisease Model Generation
Description

Custom zebrafish disease model generation service for creating validated disease models for preclinical research.

24Target Validation
CategoryTarget Validation
Description

Research service for validating therapeutic targets using zebrafish models in early drug discovery.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2014-01-01
Description

Parent company. Biobide was acquired by Bionaturis Group in 2014. In 2018, Bionaturis acquired ADL Biopharma through a reverse acquisition to form Biatgroup. Biatgroup is a biotech European leader focused on R&D and manufacturing high-value fermentation products, listed on MaB (ticker BST).

Strategic tierMinorTypeOthers
Description

Spanish biotechnology association membership providing networking and industry representation.

3Basque Health Cluster
Strategic tierMinorTypeOthers
Description

Regional health cluster membership for Basque biotech ecosystem collaboration.

biobide.com
Strategic tierMinorTypeOthers
Description

Basque biotechnology platform membership for regional industry collaboration.

5DIA Global
Strategic tierMinorTypeOthers
Description

Global regulatory science organization membership supporting regulatory affairs expertise.

biobide.com
Strategic tierMinorTypeOthers
Description

Embryo Toxicology Society membership for developmental and reproductive toxicology expertise.

7EuFishBiomed
Strategic tierMinorTypeOthers
Description

European Consortium for Biomedical Sciences using fish models.

biobide.com
8HOT (Human Occupational Toxicology Special Interest Group)
Strategic tierMinorTypeOthers
Description

Special interest group within the Society of Toxicology for occupational toxicology.

biobide.com
9LogoCILcare
Strategic tierMinorTypeOthers
Description

Nanomedicine and otology industry association membership.

biobide.com
10Safety Pharmacology Society (SPS)
Strategic tierMinorTypeOthers
Description

International society membership for safety pharmacology expertise.

biobide.com
11SETAC
Strategic tierMinorTypeOthers
Description

Society of Environmental Toxicology and Chemistry membership for ecotoxicology expertise.

biobide.com
Strategic tierMinorTypeOthers
Description

Leading toxicology society membership for scientific networking and expertise.

Strategic tierMinorTypeOthers
Description

International association for zebrafish colony management and husbandry standards.

14Hazitek Program (Basque Government)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Basque government R&D support programs including Hazitek 2024, Hazitek 2025, DanioBit 2023 projects for zebrafish technology development.

biobide.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Preclinical contract research organization providing toxicology and medical device testing services. Comparable incumbents competing in outsourced preclinical safety assessment.

TypeBroad incumbent
Description

Global preclinical CRO offering end-to-end safety assessment, including early-stage toxicology and alternative models. Represents the large incumbent against whom Biobide competes for outsourced preclinical contracts.

TypeEmerging player
Description

India-headquartered preclinical CRO expanding toxicology and safety assessment services for global pharma. Comparable emerging player offering outsourced preclinical capabilities at competitive cost.

TypeEmerging player
Description

Korean biotech company offering zebrafish embryo-based toxicology testing services. Emerging geographic peer with similar zebrafish-only CRO model in Asia.

5InDanio Bioscience
TypeEmerging player
Description

EU-focused zebrafish toxicology and drug-screening service provider. Comparable emerging niche player focused on regulatory toxicology using zebrafish models.

TypeBroad incumbent
Description

Global CRO/CDMO with extensive preclinical toxicology and safety assessment capacity. Sets the scale benchmark for outsourced preclinical services and competes for the same pharma clients.

TypeDirect peer
Description

Barcelona-based zebrafish CRO offering toxicity, efficacy, and disease-model services for pharma and biotech. Closest direct competitor to Biobide on model organism, geography, and service mix.

8Labcorp Early Development Services
TypeBroad incumbent
Description

Large-scale preclinical CRO providing safety pharmacology and toxicology services globally. Competes broadly for outsourced safety-assessment work, including alternative-model studies.

9Phylonix Services International
TypeDirect peer
Description

Massachusetts-based CRO specializing in zebrafish-based drug discovery and toxicology assays. Directly comparable as a zebrafish-only CRO serving global pharma clients.

TypeBroad incumbent
Description

Mid-to-large discovery CRO with zebrafish-related preclinical capabilities alongside broader discovery and safety-assessment services. Comparable as a multi-modal preclinical CRO with zebrafish as one offering.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BBD BioPhenix

Preclinical CRO Servicesbiobide.es

BBD BioPhenix firmographics

Firmographics
Name
BBD BioPhenix
Legal name
BBD BIOPHENIX S.L
Website
https://biobide.es
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

BBD BioPhenix industry classification

Industry
Product category
Preclinical CRO Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Preclinical drug discovery
  • Zebrafish toxicity assays
  • Contract research services
  • Ecotoxicology testing
  • GLP-compliant screening

Where BBD BioPhenix is headquartered

Location

Headquarters

HQ city
Donostia-san Sebastián
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

BBD BioPhenix business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Research Services: CRO services for pharma, biotech, chemical, cosmetic and nutraceutical companies providing preclinical zebrafish-based toxicity and efficacy testing under GLP conditions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

BBD BioPhenix product offering

Product offering

Core offering

BBD BioPhenix (Biobide) is a Contract Research Organization (CRO) providing specialized zebrafish-based preclinical testing services for drug discovery and safety assessment. The company delivers Good Laboratory Practice (GLP)-compliant toxicity and efficacy assays organized into general toxicity, specific-organ toxicity, ecotoxicology, and disease model categories. Services are conducted at its Miramon Technology Park facility in San Sebastian, which houses up to 80,000 adult zebrafish.

Product overview

Biobide (BBD BioPhenix) operates as a Contract Research Organization (CRO) providing specialized zebrafish-based testing services for preclinical drug discovery and safety assessment. The company's service portfolio includes Good Laboratory Practice (GLP)-compliant toxicity and efficacy assays organized into four main categories: General Toxicity Assays (Acutetox, Teratotox), Specific-Organ Toxicity Assays (Hepatotox, Cardiotox, Neurotox, Ototox, Immunotox, Muscle Toxicity, Kidney Toxicity, Multitox), Ecotoxicology Assays (EASZY Assay for estrogen pathway, Daphnia Immobilization, Algae Growth Inhibition, Thyroid Disruption), and Efficacy/Disease Models (Antioxidation, Regeneration, Melanin Quantification, Cancer Angiogenesis, Neurodegenerative/Rare Diseases, ALS Models, Sperm Quality, Disease Model Generation, Target Validation). The company also offers specialized reproductive services including zebrafish sperm cryopreservation and in vitro fertilization. All services are conducted at the company's Miramon Technology Park facility in San Sebastian, which houses up to 80,000 adult zebrafish.

Differentiator

Problem solved

Functional benefit

Products and services

  • Acutetox Assay General toxicity screening assay using zebrafish embryos to assess acute toxic effects of compounds, available in general and ecotoxicology variants.
  • Teratotox Assay General toxicity assay evaluating teratogenic effects (developmental malformations) in zebrafish embryos.
  • Cardiotox Assay Specific toxicity assay evaluating cardiovascular toxicity effects in zebrafish models.
  • Neurotox Assay Specific toxicity assay assessing neurotoxic effects using zebrafish models.
  • Hepatotox Assay Specific toxicity assay evaluating hepatotoxicity (liver toxicity) in zebrafish models.
  • Nephrotox/Kidney Toxicity Assay Specific toxicity assay assessing kidney toxicity effects in zebrafish models.
  • Ototox Assay Specific toxicity assay assessing ototoxicity (hearing/ear toxicity) in zebrafish models.
  • Immunotox Assay Specific toxicity assay evaluating immunotoxicity effects in zebrafish models.
  • Muscle Toxicity Assay Specific toxicity assay assessing muscle toxicity effects in zebrafish models.
  • Multitox Assay Comprehensive multi-parameter toxicity assessment screening multiple toxicity endpoints simultaneously in zebrafish.
  • EASZY Assay (Estrogen Pathway) Ecotoxicology assay evaluating estrogen pathway disruption using zebrafish, specifically designed for endocrine disruptor screening.
  • Daphnia Immobilization Test Ecotoxicology assay assessing acute toxicity to Daphnia (water fleas) for environmental hazard characterization.
  • Microplate Alga Growth Inhibition Test Ecotoxicology assay evaluating effects on algal growth for environmental toxicity assessment.
  • Thyroid Disruption Assay Ecotoxicology assay assessing thyroid endocrine disruption effects in zebrafish models.
  • Zebrafish Sperm Cryopreservation and In Vitro Fertilization Specialized reproductive biology service for zebrafish strain preservation and controlled breeding experiments.
  • Antioxidation Assay Efficacy assay evaluating antioxidant properties and effects of test compounds.
  • Regeneration Assay Efficacy assay assessing tissue regeneration capacity in zebrafish models.
  • Melanin Quantification Assay Efficacy assay for measuring melanin content and pigmentation effects in zebrafish.
  • Cancer Angiogenesis Inhibition Assay Efficacy assay evaluating anti-angiogenic properties of compounds for cancer therapeutic development.
  • Neurodegenerative and Rare Diseases Models Efficacy and disease model services for studying neurodegenerative disorders and rare diseases using zebrafish models.
  • Zebrafish Models for Amyotrophic Lateral Sclerosis (ALS) Specific disease model service using zebrafish to study ALS pathophysiology and test therapeutic candidates.
  • Sperm Quality Assessment Reproductive toxicology service evaluating zebrafish sperm quality parameters.
  • Disease Model Generation Custom zebrafish disease model generation service for creating validated disease models for preclinical research.
  • Target Validation Research service for validating therapeutic targets using zebrafish models in early drug discovery.

Quantifiable outcome

  • Reduced drug development failure rate through early toxicity screening

Companies that use BBD BioPhenix

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles5 records

BBD BioPhenix technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

BBD BioPhenix partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and minor.

  • Biatgroup (formerly Bionaturis Group)coreStrategic or Co-development Partner · 1 January 2014Parent company. Biobide was acquired by Bionaturis Group in 2014. In 2018, Bionaturis acquired ADL Biopharma through a reverse acquisition to form Biatgroup. Biatgroup is a biotech European leader focused on R&D and manufacturing high-value fermentation products, listed on MaB (ticker BST).
  • ASEBIOminorOthersSpanish biotechnology association membership providing networking and industry representation.
  • Basque Health ClusterminorOthersRegional health cluster membership for Basque biotech ecosystem collaboration.
  • BioBasqueminorOthersBasque biotechnology platform membership for regional industry collaboration.
  • DIA GlobalminorOthersGlobal regulatory science organization membership supporting regulatory affairs expertise.
  • ETSOCminorOthersEmbryo Toxicology Society membership for developmental and reproductive toxicology expertise.
  • EuFishBiomedminorOthersEuropean Consortium for Biomedical Sciences using fish models.
  • HOT (Human Occupational Toxicology Special Interest Group)minorOthersSpecial interest group within the Society of Toxicology for occupational toxicology.
  • LogoCILcareminorOthersNanomedicine and otology industry association membership.
  • Safety Pharmacology Society (SPS)minorOthersInternational society membership for safety pharmacology expertise.
  • SETACminorOthersSociety of Environmental Toxicology and Chemistry membership for ecotoxicology expertise.
  • Society of Toxicology (SOT)minorOthersLeading toxicology society membership for scientific networking and expertise.
  • ZHA (Zebrafish Husbandry Association)minorOthersInternational association for zebrafish colony management and husbandry standards.
  • Hazitek Program (Basque Government)minorStrategic or Co-development PartnerBasque government R&D support programs including Hazitek 2024, Hazitek 2025, DanioBit 2023 projects for zebrafish technology development.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

BBD BioPhenix competitors and assessment

Company assessment

Broad incumbents

  • Toxikon: Preclinical contract research organization providing toxicology and medical device testing services. Comparable incumbents competing in outsourced preclinical safety assessment.
  • Charles River Laboratories: Global preclinical CRO offering end-to-end safety assessment, including early-stage toxicology and alternative models. Represents the large incumbent against whom Biobide competes for outsourced preclinical contracts.
  • WuXi AppTec: Global CRO/CDMO with extensive preclinical toxicology and safety assessment capacity. Sets the scale benchmark for outsourced preclinical services and competes for the same pharma clients.
  • Labcorp Early Development Services: Large-scale preclinical CRO providing safety pharmacology and toxicology services globally. Competes broadly for outsourced safety-assessment work, including alternative-model studies.
  • Evotec (Zebrafish / Preclinical): Mid-to-large discovery CRO with zebrafish-related preclinical capabilities alongside broader discovery and safety-assessment services. Comparable as a multi-modal preclinical CRO with zebrafish as one offering.

Emerging players

  • Sai Life Sciences: India-headquartered preclinical CRO expanding toxicology and safety assessment services for global pharma. Comparable emerging player offering outsourced preclinical capabilities at competitive cost.
  • Bioneer Inc. Korean biotech company offering zebrafish embryo-based toxicology testing services. Emerging geographic peer with similar zebrafish-only CRO model in Asia.
  • InDanio Bioscience: EU-focused zebrafish toxicology and drug-screening service provider. Comparable emerging niche player focused on regulatory toxicology using zebrafish models.

Direct peers

  • ZeClinics: Barcelona-based zebrafish CRO offering toxicity, efficacy, and disease-model services for pharma and biotech. Closest direct competitor to Biobide on model organism, geography, and service mix.
  • Phylonix Services International: Massachusetts-based CRO specializing in zebrafish-based drug discovery and toxicology assays. Directly comparable as a zebrafish-only CRO serving global pharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

BBD BioPhenix social profiles

Digital presence

BBD BioPhenix compliance and trust

Trust signal

Compliance1 record

BBD BioPhenix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BBD BioPhenix leadership team

Management profile

Number of profiles

Profiles9 records

BBD BioPhenix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BBD BioPhenix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BBD BioPhenix

What does BBD BioPhenix do?

BBD BioPhenix (Biobide) is a Contract Research Organization (CRO) providing specialized zebrafish-based preclinical testing services for drug discovery and safety assessment. The company delivers Good Laboratory Practice (GLP)-compliant toxicity and efficacy assays organized into general toxicity, specific-organ toxicity, ecotoxicology, and disease model categories. Services are conducted at its Miramon Technology Park facility in San Sebastian, which houses up to 80,000 adult zebrafish.

Is BBD BioPhenix a public or private company?

BBD BioPhenix is a private company. It is classified as corporate owned and is currently operating.

When was BBD BioPhenix founded?

BBD BioPhenix was founded in 2005. It employs 11 to 50 people.

Where is BBD BioPhenix based?

BBD BioPhenix is headquartered in Donostia-san Sebastián, Spain, in the Europe region.

How does BBD BioPhenix make money?

One revenue line is on record: contract Research Services.

Who are BBD BioPhenix's main competitors?

Broad incumbents on record are Toxikon, Charles River Laboratories, WuXi AppTec, Labcorp Early Development Services and Evotec (Zebrafish / Preclinical). Emerging players are Sai Life Sciences, Bioneer Inc. and InDanio Bioscience. Direct peers are ZeClinics and Phylonix Services International.

Does BBD BioPhenix have an API?

No public API is recorded for BBD BioPhenix.

What industry is BBD BioPhenix in?

BBD BioPhenix's product category is Preclinical CRO Services. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales